Our top pick for
24/5 trading
Thermo Fisher Scientific Inc (TMO) is a leading diagnostics & research business with stocks listed in the US. It closed the previous market day at US$529.95. During the previous open market day, the price has varied from a low of USD526.6 to a high of USD534.84. Thermo Fisher Scientific is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Thermo Fisher Scientific
- Compare share trading platforms. To buy shares in a company listed in the US from Australia you'll need to find a trading platform that offers access to US stock markets. Look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, which will typically include your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Thermo Fisher Scientific. Find the share by name or ticker symbol: TMO. Research its history to confirm it's a solid investment that matches your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Thermo Fisher Scientific reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying using consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$529.95, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Thermo Fisher Scientific, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Thermo Fisher Scientific. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights.
Have Thermo Fisher Scientific's shares ever split?
Thermo Fisher Scientific's shares were split on a 3:2 basis on 5 June 1996. So if you had owned 2 shares the day before the split, the next day you would own 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.
Thermo Fisher Scientific shares at a glance
Information last updated 2024-11-28.
| 52-week range | US$485.7714 - US$627.4813 |
|---|---|
| 50-day moving average | US$571.7772 |
| 200-day moving average | US$577.1503 |
| Target price | US$653.94 |
| PE ratio | 32.6855 |
| Dividend yield | US$1.52 (0.3%) |
| Earnings per share (TTM) | US$15.96 |
Use the fields above to explore the returns from a historical investment. Please refer to the charts further up this page to see performance over 5 years, or other periods. Past performance doesn't indicate future results. Capital is at risk.
Thermo Fisher Scientific price performance over time
Historical closes compared with the last close of $529.95
| 1 week (2024-11-26) | 3.31% |
|---|---|
| 1 month (2024-11-01) | -5.01% |
| 3 months (2024-09-03) | -12.61% |
| 6 months (2024-06-03) | -6.96% |
| 1 year (2023-12-01) | 6.82% |
|---|---|
| 2 years (2022-12-02) | -5.87% |
| 3 years (2021-12-03) | -16.69% |
| 5 years (2019-12-03) | 69.37% |
Compare trading platforms to buy Thermo Fisher Scientific shares
1 - 5 of 26
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy Thermo Fisher Scientific stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Thermo Fisher Scientific under- or over-valued?
Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thermo Fisher Scientific's P/E ratio
Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, Thermo Fisher Scientific shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Thermo Fisher Scientific's PEG ratio
Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.9566. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Thermo Fisher Scientific's EBITDA
Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$10.6 billion (£8.3 billion).
The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure stock profitability.
Thermo Fisher Scientific share price volatility
Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as US$485.7714 up to US$627.4813. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.792. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).
Thermo Fisher Scientific financials
| Revenue TTM | US$42.4 billion |
|---|---|
| Operating margin TTM | 18.06% |
| Gross profit TTM | US$19 billion |
| Return on assets TTM | 4.67% |
| Return on equity TTM | 12.94% |
| Profit margin | 14.48% |
| Book value | 128.084 |
| Market capitalisation | US$199.5 billion |
| EBITDA | US$10.6 billion |
TTM: trailing 12 months
Thermo Fisher Scientific share dividends
Dividend payout ratio: 7.09% of net profits
Recently Thermo Fisher Scientific has paid out, on average, around 7.09% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.3% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.3% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $1.52 per share.
While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.
Thermo Fisher Scientific's most recent dividend payout was on 14 January 2025. The latest dividend was paid out to all shareholders who bought their shares by 12 December 2024 (the "ex-dividend date").
Thermo Fisher Scientific's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Thermo Fisher Scientific's total ESG risk score
Total ESG risk: 14.69
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 12/31/2018) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Thermo Fisher Scientific's environmental score
Environmental score: 2.11/100
Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Thermo Fisher Scientific's social score
Social score: 6.69/100
Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Thermo Fisher Scientific's governance score
Governance score: 3.38/100
Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Thermo Fisher Scientific's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
Thermo Fisher Scientific Inc was last rated for ESG on: 2019-01-01.
| Total ESG score | 14.69 |
|---|---|
| Total ESG percentile | 14.7 |
| Environmental score | 2.11 |
| Environmental score percentile | 1 |
| Social score | 6.69 |
| Social score percentile | 1 |
| Governance score | 3.38 |
| Governance score percentile | 1 |
| Level of controversy | 2 |
Thermo Fisher Scientific overview
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar
Thermo Fisher Scientific in the news
Thermo Fisher Scientific (TMO): Resilient Performance Despite Revenue Dip
Thermo Fisher (TMO) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Integer (ITGR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Frequently asked questions
More resources on Finder
More guides on Finder
-
Betashares Direct review
Pay zero brokerage when you invest in ASX ETFs using Betashares Direct.
-
The best options trading platforms in Australia (2024)
We've compared the fees and features of 40 trading platforms to find the best picks for options traders in Australia.
-
Best stocks under $5 in Australia (2024)
We used Finder's proprietary algorithm to find Australian-listed companies that have strong fundamentals and have a share price under $5.
-
The best ASX penny stocks (updated weekly)
Big gainers included AVJennings, Paradigm Biopharmaceuticals and SomnoMed.
-
Best performing stocks on the ASX (Updated weekly)
Top gainers included Gentrack Group, Life360, Inc. and Opthea.
-
Best ASX dividend stocks for 2024
Following a couple of lean years for dividend investors, here are 20 ideas you could consider in your portfolio.
-
Vanguard Personal Investor review
We took a look at the features and fees of the latest share trading platform.
-
The cheapest stock brokers in Australia (Dec 2024)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
-
CMC Invest review for Australia
CMC Invest account features brokerage from as low as $9.90 and a host of research and market data options.
-
Westpac Share Trading Account review
Westpac Share Trading allows you to take control of your investments. Find out if its right for you.
Ask a question